Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
British Journal of Clinical Pharmacology
|
July 24, 2025
Spotlight commentary: Using real-world data for real-world evidence generation to advance drug repurposing
George S Q Tan, Jenni Ilomäki
Frontiers in Pharmacology
|
August 28, 2023
Using administrative healthcare data to evaluate drug repurposing opportunities for cancer: the possibility of using beta-blockers to treat breast cancer
George S Q Tan, Edoardo Botteri, Stephen Wood, et al.
Drug Discovery Today
|
November 7, 2022
Drug repurposing using real-world data
George S Q Tan, Erica K Sloan, Pete Lambert, et al.
Diabetes, Obesity & Metabolism
|
November 12, 2025
Initiation of sodium-glucose cotransporter-2 inhibitors and the risk of infection-related hospitalisations: A population-based cohort study
Maria J Alfonso Arvez, George S Q Tan, Zanfina Ademi, et al.
Clinical Pharmacology and Therapeutics
|
July 27, 2025
Risk of Infections with SGLT2 Inhibitors Versus DPP4 Inhibitors: A Population-Based Cohort Study Using Antibiotic Dispensing Data
Maria J Alfonso Arvez, George S Q Tan, Sam Wade, et al.
Clinical Pharmacology and Therapeutics
|
February 9, 2024
SGLT-2 Inhibitor Use and Cause-Specific Hospitalization Rates: An Outcome-Wide Study to Identify Novel Associations of SGLT-2 Inhibitors
George S Q Tan, Jedidiah I Morton, Stephen Wood, et al.
Journal of Diabetes Research
|
October 27, 2025
SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence
Maria J Alfonso Arvez, George S Q Tan, Miriam T Y Leung, et al.
Clinical Pharmacology and Therapeutics
|
October 6, 2025
Association Discovery Approach in Healthcare Big Data to Identify Drug Safety and Drug Repurposing Signals
George S Q Tan, Lynn Miller, Sam Wade, et al.
American Journal of Epidemiology
|
September 13, 2024
Tree-based scan statistics to generate drug repurposing hypotheses: a test case using sodium-glucose cotransporter-2 inhibitors
George S Q Tan, Judith C Maro, Shirley V Wang, et al.
Journal of Diabetes
|
April 10, 2024
The association between sodium glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population-based cohort study
Kate E D Ziser, Stephen Wood, George S Q Tan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
British Journal of Clinical Pharmacology
|
July 24, 2025
Spotlight commentary: Using real-world data for real-world evidence generation to advance drug repurposing
George S Q Tan, Jenni Ilomäki
Frontiers in Pharmacology
|
August 28, 2023
Using administrative healthcare data to evaluate drug repurposing opportunities for cancer: the possibility of using beta-blockers to treat breast cancer
George S Q Tan, Edoardo Botteri, Stephen Wood, et al.
Drug Discovery Today
|
November 7, 2022
Drug repurposing using real-world data
George S Q Tan, Erica K Sloan, Pete Lambert, et al.
Diabetes, Obesity & Metabolism
|
November 12, 2025
Initiation of sodium-glucose cotransporter-2 inhibitors and the risk of infection-related hospitalisations: A population-based cohort study
Maria J Alfonso Arvez, George S Q Tan, Zanfina Ademi, et al.
Clinical Pharmacology and Therapeutics
|
July 27, 2025
Risk of Infections with SGLT2 Inhibitors Versus DPP4 Inhibitors: A Population-Based Cohort Study Using Antibiotic Dispensing Data
Maria J Alfonso Arvez, George S Q Tan, Sam Wade, et al.
Clinical Pharmacology and Therapeutics
|
February 9, 2024
SGLT-2 Inhibitor Use and Cause-Specific Hospitalization Rates: An Outcome-Wide Study to Identify Novel Associations of SGLT-2 Inhibitors
George S Q Tan, Jedidiah I Morton, Stephen Wood, et al.
Journal of Diabetes Research
|
October 27, 2025
SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence
Maria J Alfonso Arvez, George S Q Tan, Miriam T Y Leung, et al.
Clinical Pharmacology and Therapeutics
|
October 6, 2025
Association Discovery Approach in Healthcare Big Data to Identify Drug Safety and Drug Repurposing Signals
George S Q Tan, Lynn Miller, Sam Wade, et al.
American Journal of Epidemiology
|
September 13, 2024
Tree-based scan statistics to generate drug repurposing hypotheses: a test case using sodium-glucose cotransporter-2 inhibitors
George S Q Tan, Judith C Maro, Shirley V Wang, et al.
Journal of Diabetes
|
April 10, 2024
The association between sodium glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population-based cohort study
Kate E D Ziser, Stephen Wood, George S Q Tan, et al.
Page
of 2